PEAK6 Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

PEAK6 Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,400	Closed	-$413K	–	5367
2015 Q1	$413K	Sell	5,400 -11,121	-67%	-$817K	﹤0.01%	2746
2014 Q4	$1.1M	Buy	16,521 +11,768	+248%	+$784K	0.01%	1864
2014 Q3	$303K	Sell	4,753 -992	-17%	-$61.3K	﹤0.01%	2927
2014 Q2	$351K	Buy	+5,745	New	+$333K	﹤0.01%	2656

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

FIG

FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return

PEAK6 Group's PJP Position: Q2 2015 in Review

PEAK6 Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2015, closing a stake of 5,400 shares — an estimated $413K sold.

PEAK6 Group first reported a position in PJP in Q2 2014 and held it in 4 quarters. The position peaked at $1.1M in Q4 2014. 110 funds tracked by Wall St. Rank hold PJP as of Q2 2015.

PEAK6 Group reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2015 after selling out during the quarter.
PEAK6 Group sold 5,400 Invesco Pharmaceuticals ETF shares in Q2 2015, an estimated $413K.
PEAK6 Group first reported a position in Invesco Pharmaceuticals ETF in Q2 2014 and held it in 4 quarters.
PEAK6 Group's Invesco Pharmaceuticals ETF position peaked at $1.1M in Q4 2014.
110 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2015.

Based on PEAK6 Group's 13F filing for Q2 2015, filed 11 Aug 2015.